ADVERTISEMENT

ICICI Securities: Shilpa Medicare’s Jadcherla Unit In Telangana Gets U.S. FDA Warning Letter

ICICI Securities: Shilpa Medicare’s Jadcherla Unit Gets U.S. FDA Warning Letter

Capsules are arranged for a photograph in Tokyo, Japan. (Photographer: Kiyoshi Ota/Bloomberg)
Capsules are arranged for a photograph in Tokyo, Japan. (Photographer: Kiyoshi Ota/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More